Vol 6, No 4 (August 2017): Translational Lung Cancer Research (Current Knowledge and Future Perspectives on Circulating Tumor Cells in Lung Cancer)

Review Article

Circulating tumor cells and CDX models as a tool for preclinical drug development
Alice Lallo, Maximilian W. Schenk, Kristopher K. Frese, Fiona Blackhall, Caroline Dive
The clinical utility of circulating tumour cells in patients with small cell lung cancer
Victoria Foy, Fabiola Fernandez-Gutierrez, Corinne Faivre-Finn, Caroline Dive, Fiona Blackhall
Circulating tumor cell interactions with macrophages: implications for biology and treatment
Gerhard Hamilton, Barbara Rath
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Linda O’Flaherty, Harriet Wikman, Klaus Pantel
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Sumitra Mohan, Francesca Chemi, Ged Brady
Biophysical technologies for understanding circulating tumor cell biology and metastasis
Derrick W. Su, Jorge Nieva
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno


The focused issue “Current Knowledge and Future Perspectives on Circulating Tumor Cells in Lung Cancer” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Fiona Blackhall and Caroline Dive served as the unpaid Guest Editors for the focused issue.